Pharmaceuticals & Biotechnology (4570)

25,112.50
   
  • 52 Week High: 26,003.48
  • 52 Week Low: 18,687.04

Latest ShareCast News

GSK's COPD treatment approved by Chinese regulators

By Benjamin Chiou

Date: Monday 05 Jan 2026

(Sharecast News) - Pharma giant GSK has received regulatory approval in China for its Nucala treatment for adults with inadequately controlled chronic obstructive pulmonary disease (COPD).

Pharmaceuticals & Biotechnology ShareCast News

Suspension - Beximco Pharmaceuticals PLC 02-Jan-2026 ShareCast
Total Voting Rights 02-Jan-2026 ShareCast
Total Voting Rights 02-Jan-2026 ShareCast
Total Voting Rights and Capital 02-Jan-2026 ShareCast
Block Listing Return 02-Jan-2026 ShareCast

Pharmaceuticals & Biotechnology Regulatory News

Director/PDMR Shareholding 05-Jan-2026 15:30 RNS
Total Voting Rights 05-Jan-2026 15:00 RNS
Notification of Major Holding in Company 05-Jan-2026 14:34 RNS
Nucala for adults with COPD approved in China 05-Jan-2026 07:00 RNS
Directorate change 05-Jan-2026 07:00 RNS

Pharmaceuticals & Biotechnology Newspaper Links

Small companies roundup: Sinclair IS Pharma cons... 27-Nov-2014 Express & Star
MARKET REPORT: Buyers lining up for Sinclair sal... 26-Nov-2014 Daily Mail
Reneuron tests stem cell stroke treatment 03-Sep-2014 The Herald
AstraZeneca buys the rights to an asthma treatme... 13-Jun-2014 Daily Mail
AstraZeneca in new £138million asthma drug deal 13-Jun-2014 Express & Star

Pharmaceuticals & Biotechnology Tips & Analysis

Questor :GW Pharmaceuticals 04-Dec-2014 Telegraph
Questor : Hikma Pharmaceuticals 13-Mar-2014 Telegraph
Investment Column:BTG 06-Oct-2011 The Independent
Investment Column:Genus 09-Sep-2011 The Independent
Questor :Dechra Pharmaceuticals 08-Sep-2011 Telegraph

Pharmaceuticals & Biotechnology News Wires

FDA Approves Promacta(R) (Eltrombopag), the Firs... 20-Nov-2008 PR Newswire
MedImmune Announces Zook as President 13-Nov-2008 PR Newswire
Survey Shows Lung Cancer Patients Blamed for The... 12-Nov-2008 PR Newswire

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are end of day values only.

 

Price Data

Price 25,112.50
Closing Price Change -270.22
% Change -1.06 %
05-Jan-26 Close 25,112.50

Top Risers

Price Change
IMM 7.20p +16.1%
NFX 0.34p +15.3%
POLB 4.30p +10.3%
VAL 0.40p +9.6%
STX 10.50p +6.6%
GUN 0.18p +6.1%
SAR 18.00p +5.9%
AVCT 60.00p +4.3%
SCLP 10.10p +2.0%
ONT 130.00p +1.6%

Top Fallers

Price Change
OPTI 6.25p -7.4%
PRM 2.70p -5.3%
AGY 11.30p -5.0%
HEMO 548.00p -3.5%
SVNS 0.31p -3.1%
FARN 190.00p -2.6%
AZN 13,384.00p -1.5%
GENF 1.93p -1.3%
HCM 202.00p -1.0%
GNS 2,525.00p -0.8%

Top of Page